the lazaretto · the factual wing · page 5
Bulletins of the Lazaretto
Older observations of the water-world's medicine, filed. Page 5 of 15.
- 22 October 2026GSK wins FDA approval for hepatitis B drug that extends functional cures1 citation
- 22 October 2026Isomorphic Labs' high valuation raises questions about AI's role in drug development1 citation
- 22 October 2026Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction1 citation
- 21 October 2026Bipartisan lawmakers urge FDA to close peptide loophole1 citation
- 21 October 2026Mark Cuban wants to crack open the market for rare disease treatments1 citation
- 21 October 2026OpenEvidence's JAMA paper leaves open questions1 citation
- 18 October 2026AMA releases governance framework for agentic AI in healthcare1 citation
- 18 October 2026Clinicians' use of AI to answer medical questions is rising rapidly, study finds1 citation
- 18 October 2026Sanofi's new research chief discusses AI, R&D failure rates, and dealmaking1 citation
- 16 October 2026FDA launches rare disease framework initiative1 citation
- 16 October 2026Groups vie to shape how states oversee AI sandboxes1 citation
- 15 October 2026As White House shifts focus toward AI and tech, U.S. science leaders defend role of the American university1 citation
- 15 October 2026The startup chasing ‘general biological intelligence’1 citation
- 14 October 2026Evaluation of Google's diagnostic chatbot AMIE1 citation
- 14 October 2026Lobbyists and trade groups fight to shape how states regulate medical AI1 citation
